Intestinal Neoplasms: all 178 studies

Page 2 of 2. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.

• Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine TumorsTerminatedNCT01648465Phase 2
• Impact of Perioperative Intravenous Fluid Utilization on Postoperative OutcomesCompletedNCT01563991Not applicable
• Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaCompletedNCT01273090Phase 1
• Drainage After Rectal Excision for Rectal CancerCompletedNCT01269567Phase 3
• Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETsCompletedNCT01263353Phase 1
• Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Gastro-intestinal TumorsStatus unknownNCT01224990Not applicable
• Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
• Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)CompletedNCT01046864Phase 1
• Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksStatus unknownNCT01037049Phase 2
• Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerCompletedNCT01016639Phase 1/2
• Simvastatin in Colorectal SurgeryCompletedNCT00994903Phase 3
• Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
• Quality of Life in Younger Leukemia and Lymphoma SurvivorsCompletedNCT00956475
• Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic CancerTerminatedNCT00899132
• Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's LymphomaCompletedNCT00897923
• Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyTerminatedNCT00896467
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
• Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00734890Phase 1
• High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell LymphomaStatus unknownNCT00669812Phase 2
• Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
• KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentCompletedNCT00646139Phase 1
• Vaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaWithdrawnNCT00621036Phase 2
• AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaCompletedNCT00562380Phase 1
• Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaStatus unknownNCT00562068Phase 1
• Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderCompletedNCT00489515
• Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaStatus unknownNCT00445497Phase 3
• Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaStatus unknownNCT00410462Phase 2
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or LymphomaCompletedNCT00088868Phase 1
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
• Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00079261Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or LymphomaCompletedNCT00049712Phase 1
• VNP40101M in Treating Patients With Advanced or Metastatic CancerCompletedNCT00049699Phase 1
• S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionCompletedNCT00049400Phase 1
• Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
• CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous TherapyCompletedNCT00031941Phase 1
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisWithdrawnNCT00026468Phase 2/3
• Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsCompletedNCT00025441Phase 2
• VNP40101M in Treating Patients With Advanced Solid Tumors or LymphomasCompletedNCT00025129Phase 1
• Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel CancerCompletedNCT00019773Phase 1
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerCompletedNCT00019474Phase 2
• Flavopiridol in Treating Patients With Refractory CancerCompletedNCT00019344Phase 1
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasCompletedNCT00019019Phase 1
• ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00016172Phase 1
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractTerminatedNCT00012246Phase 2
• Non-Ablative Allo HSCT For Hematologic Malignancies or SAACompletedNCT00006379Phase 2
• STI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaCompletedNCT00006357Phase 1/2
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
• Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr VirusCompletedNCT00006340Phase 1
• BMS-247550 in Treating Patients With Advanced CancersCompletedNCT00006221Phase 1
• Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaCompletedNCT00006039Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaCompletedNCT00006009Phase 1
• Nitrocamptothecin in Treating Patients With Soft Tissue SarcomasCompletedNCT00005874Phase 2
• Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005804Phase 2
• Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00005639Phase 1
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00005634Phase 1
• Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00005590Phase 3
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerCompletedNCT00005049Phase 2
• Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaCompletedNCT00005021Phase 1
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionCompletedNCT00004910Phase 1/2
• Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004904Phase 1
• Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryCompletedNCT00004895Phase 2
• EMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00004258Phase 1
• Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerCompletedNCT00004189Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNCT00004066Phase 2
• PS-341 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00004002Phase 1
• Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00003993Phase 1
• Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00003939Phase 2
• Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
• Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
• Antineoplaston Therapy in Treating Patients With Cancer of the Small IntestineTerminatedNCT00003522Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisCompletedNCT00003368Phase 1
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002759Phase 1

← Intestinal Neoplasms overview